BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36624709)

  • 1. Diagnosis of Chronic Lymphocytic Leukemia Using iwCLL 2018 Compared with NCI-WG96 Criteria in Cipto Mangunkusumo Hospital: A Practical Consideration in Resource Limited Setting.
    Sukrisman L; Rinaldi I
    Acta Med Indones; 2022 Oct; 54(4):531-539. PubMed ID: 36624709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines.
    Call TG; Norman AD; Hanson CA; Achenbach SJ; Kay NE; Zent CS; Ding W; Cerhan JR; Rabe KG; Vachon CM; Hallberg EJ; Shanafelt TD; Slager SL
    Cancer; 2014 Jul; 120(13):2000-5. PubMed ID: 24711224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the incidence, pattern of presentation and clinical outcome of early chronic lymphocytic leukemia patients using the 2008 International Workshop on CLL guidelines.
    Molica S; Giannarelli D; Mirabelli R; Levato L; Gentile M; Lentini M; Morabito F
    Expert Rev Hematol; 2014 Oct; 7(5):691-5. PubMed ID: 25174547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.
    Hallek M; Cheson BD; Catovsky D; Caligaris-Cappio F; Dighiero G; Döhner H; Hillmen P; Keating MJ; Montserrat E; Rai KR; Kipps TJ;
    Blood; 2008 Jun; 111(12):5446-56. PubMed ID: 18216293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Explainable machine learning for chronic lymphocytic leukemia treatment prediction using only inexpensive tests.
    Meiseles A; Paley D; Ziv M; Hadid Y; Rokach L; Tadmor T
    Comput Biol Med; 2022 Jun; 145():105490. PubMed ID: 35405402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of bone marrow biopsy examination at diagnosis of chronic lymphocytic leukemia: a reappraisal.
    Baliakas P; Kanellis G; Stavroyianni N; Fameli M; Anagnostopoulos A; Stamatopoulos K; Papadaki T
    Leuk Lymphoma; 2013 Nov; 54(11):2377-84. PubMed ID: 23485170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed tomography scans do not improve the predictive power of 1996 national cancer institute sponsored working group chronic lymphocytic leukemia response criteria.
    Blum KA; Young D; Broering S; Lucas MS; Fischer B; Lin TS; Grever MR; Byrd JC
    J Clin Oncol; 2007 Dec; 25(35):5624-9. PubMed ID: 17984187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL).
    Molica S; Giannarelli D; Levato L; Mirabelli R; Gentile M; Lentini M; Morabito F
    Int J Hematol; 2014 Sep; 100(3):290-5. PubMed ID: 25064370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Watch and Wait in Lebanese Chronic Lymphocytic Leukemia Patients: How Relevant is it?
    Lutfallah AA; Kourie HR; Eid R; Farhat F; Ghosn M; Kattan J
    Asian Pac J Cancer Prev; 2016; 17(1):215-7. PubMed ID: 26838212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL.
    Hallek M; Cheson BD; Catovsky D; Caligaris-Cappio F; Dighiero G; Döhner H; Hillmen P; Keating M; Montserrat E; Chiorazzi N; Stilgenbauer S; Rai KR; Byrd JC; Eichhorst B; O'Brien S; Robak T; Seymour JF; Kipps TJ
    Blood; 2018 Jun; 131(25):2745-2760. PubMed ID: 29540348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal B-cell lymphocytosis in the bone marrow: revisiting the criteria for chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Ryder CB; Oduro KA; Moore EM
    Hum Pathol; 2022 Jul; 125():108-116. PubMed ID: 35472399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring.
    Dagklis A; Fazi C; Sala C; Cantarelli V; Scielzo C; Massacane R; Toniolo D; Caligaris-Cappio F; Stamatopoulos K; Ghia P
    Blood; 2009 Jul; 114(1):26-32. PubMed ID: 19029437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Lymphocytic Leukemia in Younger Adults: Preliminary Results of a Study Based on 454 Patients-IWCLL/Working Group.
    Pangalis GA; Reverter JC; Boussiotis VA; Montserrat E
    Leuk Lymphoma; 1991; 5 Suppl 1():175-8. PubMed ID: 27463502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azacitidine in fludarabine-refractory chronic lymphocytic leukemia: a phase II study.
    Malik A; Shoukier M; Garcia-Manero G; Wierda W; Cortes J; Bickel S; Keating MJ; Estrov Z
    Clin Lymphoma Myeloma Leuk; 2013 Jun; 13(3):292-5. PubMed ID: 23265768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Lymphocytic Leukemia: Clinical Stages Maintain Their Prognostic Significance Over the Course of the Disease and Are Surrogates for Response to Therapy.
    Vicente EP; Cuellar-García C; Martinez M; Soler A; Mora A; Bosch R; Brunet S; Briones J; García I; Esquirol A; Granell M; Saavedra S; Nomdedeu J; Sierra J; Martino R; Moreno C
    Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):737-742. PubMed ID: 30017595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor-Modified T Cells After Failure of Ibrutinib.
    Turtle CJ; Hay KA; Hanafi LA; Li D; Cherian S; Chen X; Wood B; Lozanski A; Byrd JC; Heimfeld S; Riddell SR; Maloney DG
    J Clin Oncol; 2017 Sep; 35(26):3010-3020. PubMed ID: 28715249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma.
    Zent CS; Ding W; Schwager SM; Reinalda MS; Hoyer JD; Jelinek DF; Tschumper RC; Bowen DA; Call TG; Shanafelt TD; Kay NE; Slager SL
    Br J Haematol; 2008 May; 141(5):615-21. PubMed ID: 18373706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress in chronic lymphocytic leukemia. International Workshop on chronic Lymphocytic Leukemia.
    Gale RP; Caligaris-Cappio F; Dighiero G; Keating M; Montserrat E; Rai K
    Leukemia; 1994 Sep; 8(9):1610-4. PubMed ID: 7522296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy.
    Rawstron AC; Kennedy B; Evans PA; Davies FE; Richards SJ; Haynes AP; Russell NH; Hale G; Morgan GJ; Jack AS; Hillmen P
    Blood; 2001 Jul; 98(1):29-35. PubMed ID: 11418459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in clinical stage identify patients with CLL and different outcome within iwCLL partial response: RESONATE study.
    Moreno C; Delgado J; Byrd JC; Zvagelsky WL; Suzuki S; Hsu E; James DF; Montserrat E
    Br J Haematol; 2019 Apr; 185(1):148-150. PubMed ID: 29855051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.